Office Based Addiction Treatment Training and Technical Assistance (OBAT TTA)

A Resource for Healthcare and Social Services Professionals

Resources

OBAT Clinical Tools and Forms

Clinical Pathway for Medication for Addiction Treatment
Download file

Words Matter
One-page handout on using medically accurate, non-stigmatizing language to talk about addiction and substance use.
Download file

Clinic Visit Documentation

Buprenorphine Initiation Note
Download file

Buprenorphine-Naloxone Maintenance Visit Checklist
Download file

Checklist Prior to Buprenorphine-Naloxone Induction
Download file

Checklist Prior to Naltrexone Induction
Download file

Initial Screening Note Template
Download file

OBAT Nurse Intake Form
Download file

OBAT Nursing Follow-up Note Template
Download file

Clinical Tool

Buprenorphine Start Guide for Patients
This is a modified version of NIDA's guidance on conducting a buprenorphine community induction that can be given out to patients.

English
Spanish

Clinical Statement from BMC Regarding Formulation Change During Pregnancy
This statement, from Project RESPECT within Boston Medical Center, details the evidence-based practice of using the buprenorphine-naloxone films for pregnant women instead of the buprenorphine monotherapy.
Download file

Considerations for Medication for Addiction Treatment in HCV+ Patients
Download file

Considerations for Medication for Addiction Treatment in Patients with HIV
Download file

COWS Scale Opioid Withdrawal Record Induction Form
Download file

DSM-5 Checklist of Diagnostic Criteria Opioid Use Disorder
Download file

Novel Naloxone Distribution Strategies
This document outlines potential strategies to increase patient access to nasal naloxone by serving as a guide for administrators, healthcare providers, and non-medical providers attempting to create reimbursable streams for naloxone.
Download file

Patient Medication Guide for Injectable Buprenorphine
Download file

Patient Medication Guide for Injectable Naltrexone (Vivitrol)

English
Spanish

Perioperative Management
This document gives management guidelines for patients maintained on buprenorphine who are scheduled for surgery or other procedures.
Download file

Pharmacotherapy for Alcohol Use Disorder
Download file

Pharmacotherapy for Opioid Use Disorder
Download file

Transfer Guidelines for Methadone to Buprenorphine or Buprenorphine to Naltrexone Transition
Download file

Consents and Treatment Agreements

Consent for Release of Information (CFR 42)

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Buprenorphine-Naloxone in Pregnancy
Download file

Consent for Treatment with Disulfiram

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Injectable Buprenorphine

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Naltrexone

English
Haitian Creole
Portuguese
Spanish

Sample OBAT Treatment Agreement

English
Haitian Creole
Portuguese
Spanish

Transmucosal Buprenorphine Consent Form

English
Haitian Creole
Portuguese
Spanish

OBAT TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for OBAT TTA is provided by:

Commonwealth of Massachusetts Department of Public Health
Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation

© 2022 Boston Medical Center. All rights reserved. Site by Signal.